In addition, the high sBCMA levels in many MM patients would decrease the efficacy of anti-BCMA ADCs since the sBCMA sequesters the anti-BCMA antibody and prevents targeting to MM cells. Here, TNFRSF17 is linked to Miyoshi myopathy.